100 related articles for article (PubMed ID: 8629373)
21. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
Ramirez RD; Sheridan S; Girard L; Sato M; Kim Y; Pollack J; Peyton M; Zou Y; Kurie JM; Dimaio JM; Milchgrub S; Smith AL; Souza RF; Gilbey L; Zhang X; Gandia K; Vaughan MB; Wright WE; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2004 Dec; 64(24):9027-34. PubMed ID: 15604268
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor genes in myeloid differentiation and leukemogenesis.
Britschgi C; Fey MF
Future Oncol; 2009 Mar; 5(2):245-57. PubMed ID: 19284382
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
Huang SM; Schönthal AH; Stallcup MR
Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
[TBL] [Abstract][Full Text] [Related]
24. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
[TBL] [Abstract][Full Text] [Related]
25. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.
Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ
Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075
[TBL] [Abstract][Full Text] [Related]
26. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
27. Papillomavirus and p53.
zur Hausen H
Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
[No Abstract] [Full Text] [Related]
28. Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblasts.
Goolsby CL; Steiner M; Nemeth J
Cytometry; 1991; 12(8):748-56. PubMed ID: 1665408
[TBL] [Abstract][Full Text] [Related]
29. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
30. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
31. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
32. The effect of functional inactivation of TP53 by HPV-E6 transformation on the induction of chromosome aberrations by gamma rays in human tumor cells.
Schwartz JL; Russell KJ
Radiat Res; 1999 Apr; 151(4):385-90. PubMed ID: 10190489
[TBL] [Abstract][Full Text] [Related]
33. Notch tumor suppressor function.
Dotto GP
Oncogene; 2008 Sep; 27(38):5115-23. PubMed ID: 18758480
[TBL] [Abstract][Full Text] [Related]
34. [Tumor suppressor gene p53--function and significance in gastroenterology].
Schoppmeyer K; Keim V; Mössner J
Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
36. Human tumor suppressor p53 and DNA viruses.
Collot-Teixeira S; Bass J; Denis F; Ranger-Rogez S
Rev Med Virol; 2004; 14(5):301-19. PubMed ID: 15334538
[TBL] [Abstract][Full Text] [Related]
37. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
Zariwala M; Liu J; Xiong Y
Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
[TBL] [Abstract][Full Text] [Related]
39. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
[TBL] [Abstract][Full Text] [Related]
40. Oncogenes and tumor suppressor genes in human lung carcinogenesis.
Iman DS; Harris CC
Crit Rev Oncog; 1991; 2(2):161-71. PubMed ID: 1649643
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
